Join us and your peers for the Emerging Biotech Upstream Forum to discuss latest trends, innovations, and technologies to accelerate your upstream process development: from cell line development to bioreactor scale up.
|8:45 - 9:00||Registration|
|9:00 - 9:50||The CHOZN® GS cell line: Optimized reagents and processes for biopharmaceutical cell line development|
|Kate Achtien, R&D Manager, MilliporeSigma|
|9:50 - 10:20||Latest Developments for Chemically-Defined Cell Culture Media and Feed|
|Tom Boilard, Sales Development Specialist - Upstream, MilliporeSigma (Rockville)|
Alexandra Steele, Sales Development Specialist - Upstream, MilliporeSigma (Cambridge)
|10:20 - 10:40||Break|
|10:40 - 11:10||Introduction to Bioreactors: Basics and Scale-up from Bench Top to Manufacturing|
|Michael Brown, Sales Development Specialist – Single-Use Bioreactors, MilliporeSigma|
|11:10 - Noon||Measuring critical quality attributes: Use the right analytical methods as your guide|
|Daniel Galbraith PhD, Director Strategy – Product Characterization Services, MilliporeSigma|
|Noon - 12:30||Lunch and Networking|
|12:30||Facility Tour (May 22 Rockville venue only)|
The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the US and Canada.
*Agenda subject to change. Attendance to the “Upstream Forum” is limited and available to pharma/biopharma manufacturers and academics only. The offer does not extend to any company that provides products or services to the pharma/biopharma industry. Merck reserves the right to revoke or refuse participation at any times.
Lunch and coffee breaks are provided courtesy of Merck. Travel costs, hotel accommodations and any other costs incurred are at the expense of the attendees.